GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
  • Research
    • Cross-cutting issues
      • Antimicrobial Resistance and Drug Discovery
      • Host–Pathogen Interactions
      • Genomic Surveillance and Population Mobility
      • Implementation and Translational Research
      • Information for Health Development
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • PRIME – Pathogen resistance, infection and molecular epidemiology
      • VBD – Vector borne diseases
      • CTM – Clinical tropical medicine
    • Research in numbers
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
    • BIOHUB & Available Software
    • BIOTROP Biobank
    • VIASEF & Insectaries
    • LABTROP & Available Equipment
  • Networks & Partnerships
Home / Publications

Artificial Intelligence Applied to the Rapid Identification of New Antimalarial Candidates with Dual-Stage Activity

  • Authors: Marilia N. N. Lima, Joyce V. B. Borba, Gustavo C. Cassiano, Melina Mottin, Sabrina S. Mendonça, Arthur C. Silva, Kaira C. P. Tomaz, Juliana Calit, Daniel Y. Bargieri, Fabio T. M. Costa, Carolina H. Andrade
  • Publication Year: 2021
  • Journal: Chemmedchem, 16(7), pp 1093-1103
  • Link: https://doi.org/10.1002/cmdc.202000685

ABSTRACT Increasing reports of multidrug-resistant malaria parasites urge the discovery of new effective drugs with different chemical scaffolds. Protein kinases play a key role in many cellular processes such as signal transduction and cell division, making them interesting targets in many diseases. Protein kinase 7 (PK7) is an orphan kinase from the Plasmodium genus, essential […]
Read More

Antimicrobial Activity of Chitosan Oligosaccharides with Special Attention to Antiparasitic Potential

  • Authors: Nayara Sousa da Silva, Nathália Kelly Araújo, Alessandra Daniele-Silva, Johny Wysllas de Freitas Oliveira, Júlia Maria de Medeiros, Renata Mendonça Araújo, Leandro De Santis Ferreira, Hugo Alexandre Oliveira Rocha, Arnóbio Antônio Silva-Junior, Marcelo Sousa-Silva, Matheus de Freitas Fernandes-Pedrosa
  • Publication Year: 2021
  • Journal: Marine Drugs, 19(2), art 110
  • Link: https://doi.org/10.3390/md19020110

ABSTRACT The global rise of infectious disease outbreaks and the progression of microbial resistance reinforce the importance of researching new biomolecules. Obtained from the hydrolysis of chitosan, chitooligosaccharides (COSs) have demonstrated several biological properties, including antimicrobial, and greater advantage over chitosan due to their higher solubility and lower viscosity. Despite the evidence of the biotechnological […]
Read More

Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients

  • Authors: Rute Marcelino, Filipa Gramacho, Francisco Martin, Pedro Brogueira, Nuno Janeiro, Claudia Afonso, Robert Badura, Emília Valadas, Kamal Mansinho, Luís Caldeira, Nuno Taveira, José M. Marcelino
  • Publication Year: 2021
  • Journal: Scientific Reports, vol 11, art 8993
  • Link: https://doi.org/10.1038/s41598-021-88274-9

ABSTRACT The ectodomain of gp41 is the target of potent binding and neutralizing antibodies (NAbs) and is being explored in new strategies for antibody-based HIV vaccines. Previous studies have suggested that the W164A-3S (3S) and EC26-2A4 (EC26) peptides located in the gp41 ectodomain may be potential HIV vaccine candidates. We assessed 3S- and EC26-specific binding […]
Read More

Antibodies response induced by recombinant virus-like particles from Triatoma virus and chimeric antigens from Trypanosoma cruzi

  • Authors: Aline Maria Vasconcelos Queiroz, Yulia Aleksandrovna Yanshina, Emily Thays da Silva Rodrigues, Fred Luciano Neves Santos, Paola Alejandra Fiorani Celedon, Sweta Maheshwari, Sandra Beatriz Gabelli, Carla Stephanie Peucelle Rubio, Aritz Durana, Diego M.A.Guérin, Marcelo Sousa-Silva
  • Link: https://doi.org/10.1016/j.vaccine.2021.05.039

ABSTRACT ‘Background:’ The infection caused by the protozoan Trypanosoma cruzi affects humans and is called as Chagas disease. Currently, the main measures available to reduce the incidence of this disease are drug treatment and vector control. Traditionally, the development of vaccines occurs mainly through the use of antigenic candidates of the etiologic agent in the […]
Read More

A Novel Allele Specific Polymerase Chain Reaction (AS-PCR) Assay to Detect the V1016G Knockdown Resistance Mutation Confirms Its Widespread Presence in Aedes albopictus Populations from Italy

  • Authors: Verena Pichler, Emiliano Mancini, Martina Micocci, Maria Calzetta, Daniele Arnoldi, Annapaola Rizzoli, Valeria Lencioni, Francesca Paoli, Romeo Bellini, Rodolfo Veronesi, Simone Martini, Andrea Drago, Claudio De Liberato, Arianna Ermenegildi, Joao Pinto, Alessandra della Torre, Beniamino Caputo
  • Journal: Insects, 12(1), art 79
  • Link: https://doi.org/10.3390/insects12010079

SIMPLE SUMMARY The Asian Tiger mosquito, Aedes albopictus, is an invasive species which has become a worldwide public health concern due to its colonization of all continents (except Antarctica), its aggressive biting behavior and its capacity to transmit potentially deadly human viruses, such as Dengue and Chikungunya. Insecticides currently represent the most commonly used weapon […]
Read More

  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 296
  • Next Page »

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Funding

UID/04413/2025 - DOI: 10.54499/UID/04413/2025

UID/PRR/04413/2025 - DOI: 10.54499/UID/PRR/04413/2025

UID/PRR2/04413/2025 - DOI: 10.54499/UID/PRR2/04413/2025

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.